{
  "disease_name": "Ornithine transcarbamylase deficiency",
  "orpha_code": "664",
  "drugs": [
    {
      "name": "RAVICTI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/445606?name=664&mode=orpha&region=",
      "regulatory_id": "445606",
      "orpha_substance_code": "ORPHA:247525",
      "details": [
        "RAVICTI(Tradename                        - 27/11/2015)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "RAVICTI(Tradename                        - 27/11/2015)",
        "(Tradename                        - 27/11/2015)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/445605?name=664&mode=orpha&region=&status=all",
          "text": "RAVICTI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90",
          "text": "ORPHA:90 Argininemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/247525",
          "text": "ORPHA:247525 Citrullinemia type I",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/445606?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:247525 Citrullinemia type I\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "AMMONAPS",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131255?name=664&mode=orpha&region=",
      "regulatory_id": "131255",
      "orpha_substance_code": "ORPHA:187",
      "details": [
        "AMMONAPS(Tradename                        - 08/12/1999)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:187 Citrullinemia",
        "AMMONAPS(Tradename                        - 08/12/1999)",
        "(Tradename                        - 08/12/1999)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:187 Citrullinemia",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/34205?name=664&mode=orpha&region=&status=all",
          "text": "AMMONAPS",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/187",
          "text": "ORPHA:187 Citrullinemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131255?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated virus serotype rh79 containing the human OTC gene, adeno-associated virus serotype rh79 encoding a meganuclease for targeted editing of the human PCSK9 gene",
      "substance_url": "/en/drug/substance/641137?name=664&mode=orpha&region=&status=all",
      "substance_id": "641137",
      "regulatory_url": "/en/drug/regulatory/641138?name=664&mode=orpha&region=",
      "regulatory_id": "641138",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Adeno-associated virus serotype rh79 containing the human OTC gene, adeno-associated virus serotype rh79 encoding a meganuclease for targeted editing of the human PCSK9 gene(Medicinal product                        - 09/12/2022)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Adeno-associated virus serotype rh79 containing the human OTC gene, adeno-associated virus serotype rh79 encoding a meganuclease for targeted editing of the human PCSK9 gene(Medicinal product                        - 09/12/2022)",
        "(Medicinal product                        - 09/12/2022)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/641137?name=664&mode=orpha&region=&status=all",
          "text": "Adeno-associated virus serotype rh79 containing the human OTC gene, adeno-associated virus serotype rh79 encoding a meganuclease for targeted editing of the human PCSK9 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641138?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "mRNA encoding modified human ornithine transcarbamylase",
      "substance_url": "/en/drug/substance/629631?name=664&mode=orpha&region=&status=all",
      "substance_id": "629631",
      "regulatory_url": "/en/drug/regulatory/629632?name=664&mode=orpha&region=",
      "regulatory_id": "629632",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "mRNA encoding modified human ornithine transcarbamylase(Medicinal product                        - 18/07/2022)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "mRNA encoding modified human ornithine transcarbamylase(Medicinal product                        - 18/07/2022)",
        "(Medicinal product                        - 18/07/2022)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/629631?name=664&mode=orpha&region=&status=all",
          "text": "mRNA encoding modified human ornithine transcarbamylase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/629632?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "sodium phenylacetate / sodium benzoate",
      "substance_url": "/en/drug/substance/87861?name=664&mode=orpha&region=&status=all",
      "substance_id": "87861",
      "regulatory_url": "/en/drug/regulatory/559562?name=664&mode=orpha&region=",
      "regulatory_id": "559562",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "sodium phenylacetate / sodium benzoate(Medicinal product                        - 24/04/2019)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "sodium phenylacetate / sodium benzoate(Medicinal product                        - 24/04/2019)",
        "(Medicinal product                        - 24/04/2019)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/87861?name=664&mode=orpha&region=&status=all",
          "text": "sodium phenylacetate / sodium benzoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/559562?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Modified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticles",
      "substance_url": "/en/drug/substance/489661?name=664&mode=orpha&region=&status=all",
      "substance_id": "489661",
      "regulatory_url": "/en/drug/regulatory/489665?name=664&mode=orpha&region=",
      "regulatory_id": "489665",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Modified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticles(Medicinal product                        - 20/04/2017)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Modified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticles(Medicinal product                        - 20/04/2017)",
        "(Medicinal product                        - 20/04/2017)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/489661?name=664&mode=orpha&region=&status=all",
          "text": "Modified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticles",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/489665?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase",
      "substance_url": "/en/drug/substance/487928?name=664&mode=orpha&region=&status=all",
      "substance_id": "487928",
      "regulatory_url": "/en/drug/regulatory/488010?name=664&mode=orpha&region=",
      "regulatory_id": "488010",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase(Medicinal product                        - 20/03/2017)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase(Medicinal product                        - 20/03/2017)",
        "(Medicinal product                        - 20/03/2017)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/487928?name=664&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/488010?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Sodium benzoate",
      "substance_url": "/en/drug/substance/83694?name=664&mode=orpha&region=&status=all",
      "substance_id": "83694",
      "regulatory_url": "/en/drug/regulatory/480440?name=664&mode=orpha&region=",
      "regulatory_id": "480440",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Sodium benzoate(Medicinal product                        - 14/07/2016)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Sodium benzoate(Medicinal product                        - 14/07/2016)",
        "(Medicinal product                        - 14/07/2016)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/83694?name=664&mode=orpha&region=&status=all",
          "text": "Sodium benzoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480440?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 8 encoding human ornithine transcarbamylase",
      "substance_url": "/en/drug/substance/458744?name=664&mode=orpha&region=&status=all",
      "substance_id": "458744",
      "regulatory_url": "/en/drug/regulatory/458748?name=664&mode=orpha&region=",
      "regulatory_id": "458748",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Adeno-associated viral vector serotype 8 encoding human ornithine transcarbamylase(Medicinal product                        - 21/03/2016)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Adeno-associated viral vector serotype 8 encoding human ornithine transcarbamylase(Medicinal product                        - 21/03/2016)",
        "(Medicinal product                        - 21/03/2016)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/458744?name=664&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 8 encoding human ornithine transcarbamylase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/458748?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Heterologous human adult liver derived stem cells",
      "substance_url": "/en/drug/substance/102674?name=664&mode=orpha&region=&status=all",
      "substance_id": "102674",
      "regulatory_url": "/en/drug/regulatory/285881?name=664&mode=orpha&region=",
      "regulatory_id": "285881",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 27/09/2011)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 27/09/2011)",
        "(Medicinal product                        - 27/09/2011)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/102674?name=664&mode=orpha&region=&status=all",
          "text": "Heterologous human adult liver derived stem cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/285881?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Glycerol phenylbutyrate",
      "substance_url": "/en/drug/substance/222387?name=664&mode=orpha&region=&status=all",
      "substance_id": "222387",
      "regulatory_url": "/en/drug/regulatory/240238?name=664&mode=orpha&region=",
      "regulatory_id": "240238",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Glycerol phenylbutyrate(Medicinal product                        - 10/06/2010)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Glycerol phenylbutyrate(Medicinal product                        - 10/06/2010)",
        "(Medicinal product                        - 10/06/2010)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/222387?name=664&mode=orpha&region=&status=all",
          "text": "Glycerol phenylbutyrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/240238?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Heterologous human adult liver derived stem cells",
      "substance_url": "/en/drug/substance/102674?name=664&mode=orpha&region=&status=all",
      "substance_id": "102674",
      "regulatory_url": "/en/drug/regulatory/132403?name=664&mode=orpha&region=",
      "regulatory_id": "132403",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 04/02/2008)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 04/02/2008)",
        "(Medicinal product                        - 04/02/2008)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/102674?name=664&mode=orpha&region=&status=all",
          "text": "Heterologous human adult liver derived stem cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/132403?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Human heterologous liver cells (for infusion)",
      "substance_url": "/en/drug/substance/90800?name=664&mode=orpha&region=&status=all",
      "substance_id": "90800",
      "regulatory_url": "/en/drug/regulatory/134146?name=664&mode=orpha&region=",
      "regulatory_id": "134146",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Human heterologous liver cells (for infusion)(Medicinal product                        - 14/09/2007)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Human heterologous liver cells (for infusion)(Medicinal product                        - 14/09/2007)",
        "(Medicinal product                        - 14/09/2007)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90800?name=664&mode=orpha&region=&status=all",
          "text": "Human heterologous liver cells (for infusion)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/134146?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Codon -optimised human ornithine transcarbamylase mRNA  complexed with lipid -based  nanoparticle",
      "substance_url": "/en/drug/substance/520928?name=664&mode=orpha&region=&status=all",
      "substance_id": "520928",
      "regulatory_url": "/en/drug/regulatory/520929?name=664&mode=orpha&region=",
      "regulatory_id": "520929",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Codon -optimised human ornithine transcarbamylase mRNA  complexed with lipid -based  nanoparticle(Medicinal product                        - 27/06/2018)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Codon -optimised human ornithine transcarbamylase mRNA  complexed with lipid -based  nanoparticle(Medicinal product                        - 27/06/2018)",
        "(Medicinal product                        - 27/06/2018)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/520928?name=664&mode=orpha&region=&status=all",
          "text": "Codon -optimised human ornithine transcarbamylase mRNA  complexed with lipid -based  nanoparticle",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/520929?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Sodium phenylbutyrate",
      "substance_url": "/en/drug/substance/25062?name=664&mode=orpha&region=&status=all",
      "substance_id": "25062",
      "regulatory_url": "/en/drug/regulatory/301037?name=664&mode=orpha&region=",
      "regulatory_id": "301037",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Sodium phenylbutyrate(Medicinal product                        - 09/02/2012)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Sodium phenylbutyrate(Medicinal product                        - 09/02/2012)",
        "(Medicinal product                        - 09/02/2012)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/25062?name=664&mode=orpha&region=&status=all",
          "text": "Sodium phenylbutyrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/301037?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PHEBURANE",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/628626?name=664&mode=orpha&region=",
      "regulatory_id": "628626",
      "orpha_substance_code": "ORPHA:147",
      "details": [
        "PHEBURANE(Tradename                        - 17/06/2022)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "PHEBURANE(Tradename                        - 17/06/2022)",
        "(Tradename                        - 17/06/2022)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/628534?name=664&mode=orpha&region=&status=all",
          "text": "PHEBURANE",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/628626?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "RAVICTI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/465104?name=664&mode=orpha&region=",
      "regulatory_id": "465104",
      "orpha_substance_code": "ORPHA:247525",
      "details": [
        "RAVICTI(Tradename                        - 01/02/2013)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "RAVICTI(Tradename                        - 01/02/2013)",
        "(Tradename                        - 01/02/2013)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/445605?name=664&mode=orpha&region=&status=all",
          "text": "RAVICTI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90",
          "text": "ORPHA:90 Argininemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/247525",
          "text": "ORPHA:247525 Citrullinemia type I",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/465104?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:247525 Citrullinemia type I\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "BUPHENYL",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131075?name=664&mode=orpha&region=",
      "regulatory_id": "131075",
      "orpha_substance_code": "ORPHA:147",
      "details": [
        "BUPHENYL(Tradename                        - 30/04/1996)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "BUPHENYL(Tradename                        - 30/04/1996)",
        "(Tradename                        - 30/04/1996)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/25061?name=664&mode=orpha&region=&status=all",
          "text": "BUPHENYL",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131075?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase",
      "substance_url": "/en/drug/substance/487928?name=664&mode=orpha&region=&status=all",
      "substance_id": "487928",
      "regulatory_url": "/en/drug/regulatory/661646?name=664&mode=orpha&region=",
      "regulatory_id": "661646",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase(Medicinal product                        - 08/08/2023)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase(Medicinal product                        - 08/08/2023)",
        "(Medicinal product                        - 08/08/2023)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/487928?name=664&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661646?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Replication-deficient adeno-associated virus serotype 9 vector containing the ornithine transcarbamylase gene within the transposon and a lipid nanoparticle containing messenger RNA for the transposase",
      "substance_url": "/en/drug/substance/661817?name=664&mode=orpha&region=&status=all",
      "substance_id": "661817",
      "regulatory_url": "/en/drug/regulatory/661818?name=664&mode=orpha&region=",
      "regulatory_id": "661818",
      "orpha_substance_code": "ORPHA:664",
      "details": [
        "Replication-deficient adeno-associated virus serotype 9 vector containing the ornithine transcarbamylase gene within the transposon and a lipid nanoparticle containing messenger RNA for the transposase(Medicinal product                        - 24/07/2023)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "Replication-deficient adeno-associated virus serotype 9 vector containing the ornithine transcarbamylase gene within the transposon and a lipid nanoparticle containing messenger RNA for the transposase(Medicinal product                        - 24/07/2023)",
        "(Medicinal product                        - 24/07/2023)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661817?name=664&mode=orpha&region=&status=all",
          "text": "Replication-deficient adeno-associated virus serotype 9 vector containing the ornithine transcarbamylase gene within the transposon and a lipid nanoparticle containing messenger RNA for the transposase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661818?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Allogeneic adult liver-derived stem cells",
      "substance_url": "/en/drug/substance/629851?name=664&mode=orpha&region=&status=all",
      "substance_id": "629851",
      "regulatory_url": "/en/drug/regulatory/629852?name=664&mode=orpha&region=",
      "regulatory_id": "629852",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Allogeneic adult liver-derived stem cells(Medicinal product                        - 10/08/2022)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Allogeneic adult liver-derived stem cells(Medicinal product                        - 10/08/2022)",
        "(Medicinal product                        - 10/08/2022)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/629851?name=664&mode=orpha&region=&status=all",
          "text": "Allogeneic adult liver-derived stem cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/629852?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end",
      "substance_url": "/en/drug/substance/688360?name=664&mode=orpha&region=&status=all",
      "substance_id": "688360",
      "regulatory_url": "/en/drug/regulatory/688517?name=664&mode=orpha&region=",
      "regulatory_id": "688517",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end(Medicinal product                        - 11/09/2024)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end(Medicinal product                        - 11/09/2024)",
        "(Medicinal product                        - 11/09/2024)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/688360?name=664&mode=orpha&region=&status=all",
          "text": "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/688517?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Glycerol phenylbutyrate",
      "substance_url": "/en/drug/substance/222387?name=664&mode=orpha&region=&status=all",
      "substance_id": "222387",
      "regulatory_url": "/en/drug/regulatory/238146?name=664&mode=orpha&region=",
      "regulatory_id": "238146",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Glycerol phenylbutyrate(Medicinal product                        - 27/04/2009)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Glycerol phenylbutyrate(Medicinal product                        - 27/04/2009)",
        "(Medicinal product                        - 27/04/2009)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/222387?name=664&mode=orpha&region=&status=all",
          "text": "Glycerol phenylbutyrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/238146?name=664&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:00:34.520056",
  "run_number": 1,
  "total_drugs_found": 23,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Ornithine+transcarbamylase+deficiency&orphaCode=664&name=664&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Ornithine transcarbamylase deficiency",
    "orphaCode": "664",
    "name": "664",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}